WATCH ON-DEMAND
Digital Forum | Available On-Demand
5th Annual Pharma Market Access and Pricing Asia
Build Effective Go-To-Market Strategies with Faster Access to Emerging Markets
Access to drugs is improving across Asia as the pharmaceutical industry continues to grow rapidly in this region. Key concerns now revolve around suitable pricing strategies, sourcing for alternative payers, procurement considerations, efficient methods to prove value of the drug and the introduction of HTA for growing economies.
Delivered digitally, the 5th Annual Pharma Market Access and Pricing Asia will bring together pharma manufacturers, the biotech startups, technology and service providers, along with key government stakeholders to address speed-to-market strategies, approaches to pricing and market access negotiations for the APAC markets.
SPEAKERS 2022
Key Topics Include....
Gain access to a 2-hour discussion on market access and pricing strategies to accelerate your entry to emerging markets whilst managing costs.
The Next Pharma Industry Priorities
Accelerating Market Access in APAC
Insurance-Pharma Partnership Considerations
How Would Pricing Strategies Help Manage Increasing Costs?
Comparison of Regional Pricing Strategies
Pricing Regulation Analysis in Asia
Why Attend?
Build an effective go-to-market strategies with faster access to markets like India & China by learning from our top experts and practitioners from the pharma industries.
Gain access to a 2-hour discussion on market access and pricing strategies to accelerate your entry to emerging markets whilst managing costs.
Exchange knowledge and network with top regional thought leaders during and after the event to upskill your knowledge on the product distribution strategy.
Official Sponsor
Deallus is a global life science consultancy with a heritage in Competitive Intelligence.
Their vision is to lead the industry in shaping and refining strategies for those striving to advance healthcare and improve patients’ lives. For two decades Deallus has been the partner of choice for pharma, biotech, and med-tech to help our clients achieve this. Today, Deallus work alongside the world’s global leading pharma companies, as well as emerging biopharma, partnering with their clients across multiple projects and over many years.
They are a team of commercial scientists which allows for a peer-to-peer partnerships with their clients through a shared understanding of how science intersects with commercial market realities. For their clients, Deallus become an extension of their internal teams, enabling them to generate bespoke solutions to organisational needs and ambitions. Operating in key pharma markets, they retain and develop top talent, nurturing their team by cultivating a diverse and inclusive culture.
Clients value their expertise in market dynamics and depth of therapeutic areas to deliver the actionable insights that drive innovation.
Their therapy area expertise, including neuroscience, oncology, rare diseases, and vaccines, and global reach serve clients areas including: business insights, market access, value and pricing, R&D, portfolio strategy, medical affairs, and brand and marketing. Their outputs are tailored to the client challenge and leveraging a range of methodologies including primary research, market landscaping, workshops, and forecasting.
UNLOCK LIMITLESS OPPORTUNITIES BY ATTENDING A FASTFORUMS EVENT
Capitalise on the unique opportunity to ask questions and network with industry thought leaders and uncover vital best practices.
Make exclusive connections that will help you grow your business and establish brand presence in a burgeoning market
Understand the challenges and opportunities related to product development, manufacturing, registration, distribution, marketing and quality management of Pharmaceutical products